Actively Recruiting

Phase Not Applicable
Age: 18Years - 85Years
All Genders
ID06349577

Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury: Randomized Controlled Trial

Led by University of Colorado, Denver · Updated on 2025-05-21

1100

Participants Needed

1

Research Sites

26 weeks

Total Duration

On this page

Sponsors

U

University of Colorado, Denver

Lead Sponsor

N

National Heart, Lung, and Blood Institute (NHLBI)

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are evaluating the effectiveness of pulsatile blood flow during cardiopulmonary bypass to reduce the risk of acute kidney injury following cardiac surgery. Pulsatile flow mimics the natural pulse of a beating heart, compared to non-pulsatile flow which provides a constant blood flow. The study aims to compare these two methods to see if pulsatile flow improves clinical outcomes after surgery, particularly kidney health. Participants will be randomly assigned to receive either pulsatile or non-pulsatile blood flow during their cardiopulmonary bypass procedure. Both methods are standard care approaches used to maintain blood circulation while the heart is stopped during surgery. Pulsatile flow is generated by varying the pump rate to create pulses, while non-pulsatile flow uses a constant pump rate. The study does not involve masking or blinding. During the study, participants will be monitored from the time they enter the intensive care unit after surgery for up to seven days to assess kidney injury and other outcomes. Researchers will track acute kidney injury, blood transfusions, platelet counts, and mortality up to 30 days after surgery. The study will also observe the use and discontinuation of bypass modes and monitor safety. The total participation timeline includes the surgery and follow-up assessments in the hospital.

CONDITIONS

Brief Title

Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Able to provide informed consent
  • Scheduled for elective cardiac surgery with cardiopulmonary bypass
  • Age between 18 and 85 years
Not Eligible

You will not qualify if you...

  • Emergency procedures
  • Scheduled for heart or lung transplantation
  • Scheduled for ventricular assist device implantation
  • Use of the Medtronic Elongated Once-Piece Arterial Cannula
  • Diagnosed with sepsis
  • Diagnosed with delirium
  • Experiencing hemodynamic instability (heart rate > 100 and systolic blood pressure < 90)
  • Requiring mechanical circulatory support
  • Requiring vasoactive medications

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Surgery and Immediate Post-operative Care

Duration - Surgery day and up to 7 days post-surgery

Participants undergo cardiac surgery with cardiopulmonary bypass using either pulsatile or non-pulsatile blood flow during the procedure.

Monitoring during surgery and intensive care unit stay

Post-operative Follow-up

Duration - Up to 30 days after surgery

Participants are monitored for acute kidney injury and other outcomes after surgery until hospital discharge or up to 30 days.

Visits during intensive care unit stay and hospital discharge assessments

Trial Site Locations

Total: 1 location

1

University of Colorado Hospital

Aurora, Colorado, United States, 80045

Actively Recruiting

Loading map...

Research Team

N

Nathan J Clendenen, MD,MS

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Similar Trials

Clinical Outcomes of Indocyanine Green Tracer in 3D Plus Ult...

Gastric Cancer

Actively Recruiting

1 location

Evaluating the Clinical Value of 68Ga-TCR-FAPI PET/CT to Gui...

Medullary Thyroid Cancer

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Predictive Accuracy of a Perioperative Laboratory Test-Based Prediction Model for Moderate to Severe Acute Kidney Injury After Cardiac Surgery.

Sevag Demirjian, C Allen Bashour, Andrew Shaw...

https://pubmed.ncbi.nlm.nih.gov/35258532